Our profiling of HML-2 transcription in ALS opens up the possibility that HML-2 proteins other than canonical full-length Env may have to be considered when studying the role of HML-2 in ALS disease. The gene discussed is CLEC10A; the disease is amyotrophic lateral sclerosis.